The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options
Abstract
Multidrug-resistant Acinetobacter baumannii is recognized to be among the most difficult antimicrobial-resistant gram-negative bacilli to control and treat. Increasing antimicrobial resistance among Acinetobacter isolates has been documented, although definitions of multidrug resistance vary in the literature. A. baumannii survives for prolonged periods under a wide range of environmental conditions. The organism causes outbreaks of infection and health care-associated infections, including bacteremia, pneumonia, meningitis, urinary tract infection, and wound infection. Antimicrobial resistance greatly limits the therapeutic options for patients who are infected with this organism, especially if isolates are resistant to the carbapenem class of antimicrobial agents. Because therapeutic options are limited for multidrug-resistant Acinetobacter infection, the development or discovery of new therapies, well-controlled clinical trials of existing antimicrobial regimens and combinations, and greater emphasis on the prevention of health care-associated transmission of multidrug-resistant Acinetobacter infection are essential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Fournier, P. E., Richet, H., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500202 · Cited by 995
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
Bonomo, R. A., & Szabo, D. (2006) · Clinical Infectious Diseases · doi:10.1086/504477 · Cited by 741
Levin, A. S., Barone, A. A., Penço, J., Santos, M. V., Marinho, I. S., Arruda, E. A. G., Manrique, E. I., & Costa, S. F. (1999) · Clinical Infectious Diseases · doi:10.1086/514732 · Cited by 612
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 571
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Hujer, K. M., Hujer, A. M., Hulten, E. A., Bajaksouzian, S., Adams, J. M., Donskey, C. J., Ecker, D. J., Massire, C., Eshoo, M. W., Sampath, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-06 · Cited by 480
Garnacho‐Montero, J., Ortiz‐Leyba, C., Jimenez‐Jimenez, F. J., Barrero‐Almodovar, A. E., Garcia‐Garmendia, J. L., Bernabeu‐WittelI, M., Gallego‐Lara, S. L., & Madrazo‐Osuna, J. (2003) · Clinical Infectious Diseases · doi:10.1086/374337 · Cited by 470
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Sunenshine, R. H., Wright, M.-O., Maragakis, L. L., Harris, A. D., Song, X., Hebden, J., Cosgrove, S. E., Anderson, A., Carnell, J., Jernigan, D. B., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060716 · Cited by 411
Self-citationAcinetobacter Outbreaks, 1977–2000
Villegas, M. V., & Hartstein, A. I. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502205 · Cited by 402
Falagas, M. E., Koletsi, P. K., & Bliziotis, I. A. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46747-0 · Cited by 399
Lockhart, S. R., Abramson, M. A., Beekmann, S. E., Gallagher, G., Riedel, S., Diekema, D. J., Quinn, J. P., & Doern, G. V. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01284-07 · Cited by 396
Scott, P., Deye, G., Srinivasan, A., Murray, C., Moran, K., Hulten, E., Fishbain, J., Craft, D., Riddell, S., Lindler, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518170 · Cited by 393
Corbella, X., Montero, A., Pujol, M., Domínguez, M. A., Ayats, J., Argerich, M. J., Garrigosa, F., Ariza, J., & Gudiol, F. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4086-4095.2000 · Cited by 348
Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers
Davis, K. A., Moran, K. A., McAllister, C. K., & Gray, P. J. (2005) · Emerging Infectious Diseases · doi:10.3201/1108.050103 · Cited by 327
Manikal, V. M., Landman, D., Saurina, G., Oydna, E., Lal, H., & Quale, J. (2000) · Clinical Infectious Diseases · doi:10.1086/313902 · Cited by 309
Gales, A. C., Jones, R. N., & Sader, H. S. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01351.x · Cited by 302
Multidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
Markou, N., Apostolakos, H., Koumoudiou, C., Athanasiou, M., Koutsoukou, A., Alamanos, I., & Gregorakos, L. (2003) · Critical Care · doi:10.1186/cc2358 · Cited by 278
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings
Garnacho-Montero, J., Ortiz-Leyba, C., Fernández-Hinojosa, E., Aldabó-Pallás, T., Cayuela, A., Marquez-Vácaro, J. A., Garcia-Curiel, A., & Jiménez-Jiménez, F. J. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2598-0 · Cited by 276
Mussi, M. A., Limansky, A. S., & Viale, A. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1432-1440.2005 · Cited by 276
Seifert, H., Strate, A., & Pulverer, G. (1995) · Medicine · doi:10.1097/00005792-199511000-00004 · Cited by 259
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii
Peleg, A. Y., Adams, J., & Paterson, D. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01198-06 · Cited by 257
Playford, E. G., Craig, J. C., & Iredell, J. R. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.11.010 · Cited by 251
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Peleg, A. Y., Potoski, B. A., Rea, R., Adams, J., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V., & Paterson, D. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl441 · Cited by 248
Bou, G., Oliver, A., & Martínez-Beltrán, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1556-1561.2000 · Cited by 247
Ruzin, A., Keeney, D., & Bradford, P. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm058 · Cited by 238
The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!
Thomson, J. M., & Bonomo, R. A. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.014 · Cited by 212
Urban, C., Segal‐Maurer, S., & Rahal, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/374847 · Cited by 211
Jawad, A., Heritage, J. C., Snelling, A. M., Gascoyne‐Binzi, D., & Hawkey, P. M. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.2881-2887.1996 · Cited by 202
Bonomo, R. A. (2000) · Clinical Infectious Diseases · doi:10.1086/317489 · Cited by 201
Simor, A. E., Lee, M., Vearncombe, M., Jones-Paul, L., Barry, C., Gomez, M., Fish, J. S., Cartotto, R. C., Palmer, R., & Louie, M. (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/502046 · Cited by 198
Lee, N.-Y., Lee, H.-C., Ko, N.-Y., Chang, C.-M., Shih, H.-I., Wu, C.-J., & Ko, W.-C. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/517954 · Cited by 198
Coelho, J. M., Turton, J. F., Kaufmann, M. E., Glover, J., Woodford, N., Warner, M., Palepou, M.-F., Pike, R., Pitt, T. L., Patel, B. C., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00699-06 · Cited by 191
OXA β-lactamases in Acinetobacter: the story so far
Brown, S., & Amyes, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki425 · Cited by 189
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
Kwon, K. T., Oh, W. S., Song, J.-H., Chang, H.-H., Jung, S.-I., Kim, S.-W., Ryu, S. Y., Heo, S. T., Jung, D. S., Rhee, J.-Y., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl499 · Cited by 188
Blot, S., Vandewoude, K., & Colardyn, F. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1648-8 · Cited by 177
Bacteriology of War Wounds at the Time of Injury
Murray, C. K., Roop, S. A., Hospenthal, D. R., Dooley, D. P., Wenner, K., Hammock, J., Taufen, N., & Gourdine, E. (2006) · Military Medicine · doi:10.7205/milmed.171.9.826 · Cited by 176
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Owen, R. J., Li, J., Nation, R. L., & Spelman, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl512 · Cited by 176
Risk Factors for Acquisition of Imipenem-Resistant Acinetobacter baumannii : a Case-Control Study
Lee, S.-O., Kim, N. J., Choi, S.-H., Kim, T. H., Chung, J.-W., Woo, J.-H., Ryu, J., & Kim, Y. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.224-228.2004 · Cited by 175
Rice, L. B. (2006) · Clinical Infectious Diseases · doi:10.1086/504487 · Cited by 175
Wood, G. C., Hanes, S. D., Croce, M. A., Fabian, T. C., & Boucher, B. A. (2002) · Clinical Infectious Diseases · doi:10.1086/340055 · Cited by 174
Wang, S. H., Sheng, W., Chang, Y.-Y., Wang, L., Lin, H.-Y., Chen, M. L., Pan, H.-J., Ko, W.-J., Chang, S., & Lin, F. Y. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1348 · Cited by 164
Levin, A. S., Levy, C. E., Manrique, A. E. I., Medeiros, E. A. S., & Costa, S. F. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00276-5 · Cited by 159
Garnacho, J., Sole-Violan, J., Sa-Borges, M., Diaz, E., & Rello, J. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000089936.09573.f3 · Cited by 159
Montero, A., Ariza, J., Corbella, X., Doménech, A., Cabellos, C., Ayats, J., Tubau, F., Borraz, C., & Gudiol, F. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh485 · Cited by 158
Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues
Cornaglia, G., Akova, M., Amicosante, G., Cantón, R., Cauda, R., Docquier, J., Edelstein, M. V., Frère, J., Füzi, M., Galleni, M., et al. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.10.008 · Cited by 151
Falagas, M. E., Bliziotis, I. A., & Tam, V. H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.024 · Cited by 151
Sobieszczyk, M. E. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh369 · Cited by 147
Higgins, P. G., Wisplinghoff, H., Stefanik, D., & Seifert, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1586-1592.2004 · Cited by 142
Parenteral and Inhaled Colistin for Treatment of Ventilator-Associated Pneumonia
Linden, P. K., & Paterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504485 · Cited by 122
Rodríguez-Hernández, M. J., Pachón, J., Pichardo, C., Cuberos, L., Ibáñez-Martínez, J., García-Curiel, A., Caballero, F. J., Moreno, I., & Me, J.-M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.493 · Cited by 117
Susceptibility of Acinetobacter Strains Isolated from Deployed U.S. Military Personnel
Hawley, J. S., Murray, C. K., Griffith, M. E., McElmeel, M. L., Fulcher, L. C., Hospenthal, D. R., & Jorgensen, J. H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00858-06 · Cited by 116
Maragakis, L. L. (2004) · JAMA · doi:10.1001/jama.292.24.3006 · Cited by 109
Self-citationCoelho, J., Woodford, N., Afzal-Shah, M., & Livermore, D. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.756-758.2006 · Cited by 104
Falagas, M. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl130 · Cited by 102
Harris, A. D., McGregor, J. C., & Furuno, J. P. (2006) · Clinical Infectious Diseases · doi:10.1086/504479 · Cited by 102
Bacteria Recovered from Patients Admitted to a Deployed U.S. Military Hospital in Baghdad, Iraq
Yun, H. C., Murray, C. K., Roop, S. A., Hospenthal, D. R., Gourdine, E., & Dooley, D. P. (2006) · Military Medicine · doi:10.7205/milmed.171.9.821 · Cited by 98
Saballs, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl274 · Cited by 93
The Brooklyn Antibiotic Resistance Task Force (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502018 · Cited by 90
Holloway, K. P., Rouphael, N., Wells, J. B., King, M. D., & Blumberg, H. M. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h353 · Cited by 84
Pantopoulou, A., Giamarellos‐Bourboulis, E. J., Raftogannis, M., Τσαγανός, Θ., Dontas, I. A., Koutoukas, P., Baziaka, F., Giamarellou, H., & Perrea, D. N. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.09.009 · Cited by 77
Zanetti, G., Blanc, D., Federli, I., Raffoul, W., Pétignat, C., Maravic, P., Francioli, P. B., & Berger, M. M. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/517956 · Cited by 77
Bernabeu‐Wittel, M., Pichardo, C., García-Curiel, A., Pachón-Ibáñez, M. E., Ibáñez-Martínez, J., Me, J.-M., & Pachón, J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01095.x · Cited by 64
AcinetobacterSkin Carriage Among US Army Soldiers Deployed in Iraq
Griffith, M. E., Lazarus, D. R., Mann, P. B., Boger, J. A., Hospenthal, D. R., & Murray, C. K. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/518966 · Cited by 55
Brauers, J., Frank, U., Kresken, M., Rodloff, A. C., & Seifert, H. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01015.x · Cited by 43
Sader, H. S., & Jones, R. N. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.01.011 · Cited by 40
Amikacin and colistin for treatment of Acinetobacter baumannii meningitis
Fulnecky, E. J., Wright, D., Scheld, W. M., Kanawati, L., & Shoham, S. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.04.003 · Cited by 39
Shirawi, N., Memish, Z. A., Cherfan, A. J., & Shimemeri, A. A. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.5.554 · Cited by 29
Carbapenem Susceptibility Discords among Acinetobacter Isolates
Jones, R., Sader, H. S., Fritsche, T. R., & Rhomberg, P. R. (2005) · Clinical Infectious Diseases · doi:10.1086/498754 · Cited by 26
Discordance of meropenem versus imipenem activity against Acinetobacter baumannii
Ikonomidis, A., Pournaras, S., Maniatis, A. N., et al. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.07.007 · Cited by 23
Cited by
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Weber, D. J., Rutala, W. A., Miller, M. B., Huslage, K., & Sickbert-Bennett, E. (2010) · American Journal of Infection Control · doi:10.1016/j.ajic.2010.04.196 · Cited by 768
The Scourge of Antibiotic Resistance: The Important Role of the Environment
Finley, R. L., Collignon, P., Larsson, D. G. J., McEwen, S. A., Li, X.-Z., Gaze, W. H., Reid-Smith, R., Timinouni, M., Graham, D. W., & Topp, E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit355 · Cited by 636
Metadata
- Authors
- Maragakis, L. L., & Perl, T. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04-15
- Volume
- 46
- Issue
- 8
- Pages
- 1254-1263
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2149500566
- Cited by
- 969
- References
- 76
- FWCI
- 19.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.